Metsera: The Weight Loss Startup That’s Turning Heads Metsera, a three-year-old mid-stage clinical obesity startup, has suddenly found itself in…
Browsing: Pfizer
The battle against obesity has taken an unexpected turn, as Novo Nordisk has made a bold bid to acquire Metsera,…
WASHINGTON, DC: U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla in the Oval Office of the White…
In recent news, the agreement between Pfizer and the Trump administration to lower drug prices has caused a ripple effect…
Pfizer CEO Albert Bourla speaks shakes hands with U.S. President Donald Trump in a White House event on Tuesday.Getty Images…
Trump secures victory with drugmakers deal The deal is a victory for Trump President Trump has successfully pressured drugmakers to…
Pfizer Makes Bold Move into Obesity Market with $4.9 Billion Metsera Acquisition Pfizer is making waves in the pharmaceutical world…
The FDA has requested Moderna and Pfizer-BioNTech to expand the age range of boys and young men at risk for…
The Success Story of Mirdametinib: A Lesson in Rescuing Shelved Pharma Assets Once destined for Pfizer’s R&D junk pile, the…
Pfizer Halts Development of Obesity Pill Due to Liver Injury Concerns Pfizer has made the decision to discontinue the development…
